Active Ingredient: POSACONAZOLE
Proprietary Name: POSACONAZOLE
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A214476
Product Number: 001
Approval Date: Feb 4, 2022
Applicant Holder Full Name: BIOCON PHARMA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information